Status and phase
Conditions
Treatments
About
The present study is a 3-arm randomized controlled pilot study. Participants who call the Maryland Tobacco Quitline and are eligible for study participation are randomized to receive quitline tobacco cessation treatment as usual (TAU), TAU plus remote carbon monoxide (CO) monitoring via smartphone app, or TAU plus remote carbon monoxide monitoring plus incentives vis smartphone app. The investigators hypothesize that remote CO monitoring will be feasible and acceptable to deliver in the quitline setting, will increase treatment engagement, and will increase tobacco cessation and treatment satisfaction rates.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
• Pregnant or breast feeding
Primary purpose
Allocation
Interventional model
Masking
229 participants in 3 patient groups
Loading...
Central trial contact
Kelly Carpenter, PhD; Caryn Chalmers, MPH
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal